Weiss Ratings reiterated their sell (d-) rating on shares of Zepp Health (NYSE:ZEPP – Free Report) in a research report report published on Friday,Weiss Ratings reports.
ZEPP has been the subject of several other reports. Fundamental Research set a $60.23 target price on shares of Zepp Health and gave the company a “buy” rating in a research note on Tuesday, August 26th. Wall Street Zen upgraded Zepp Health to a “hold” rating in a report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, Zepp Health presently has an average rating of “Hold” and an average target price of $60.23.
Get Our Latest Stock Analysis on Zepp Health
Zepp Health Stock Down 7.6%
Institutional Investors Weigh In On Zepp Health
A hedge fund recently bought a new stake in Zepp Health stock. Ariose Capital Management Ltd bought a new position in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP – Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 27,717 shares of the company’s stock, valued at approximately $1,269,000. Zepp Health comprises 0.4% of Ariose Capital Management Ltd’s portfolio, making the stock its 27th largest position. Ariose Capital Management Ltd owned approximately 0.19% of Zepp Health as of its most recent filing with the SEC. 52.61% of the stock is currently owned by institutional investors and hedge funds.
Zepp Health Company Profile
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Read More
- Five stocks we like better than Zepp Health
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- 3 REITs to Buy and Hold for the Long Term
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Using the MarketBeat Stock Split Calculator
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
